Clinical and serological heterogeneity in patients with anticentromere antibodiesMIYAWAKI, Shoji; ASANUMA, Hiroko; NISHIYAMA, Susumu et al.Journal of rheumatology. 2005, Vol 32, Num 8, pp 1488-1494, issn 0315-162X, 7 p.Article

Phase I clinical trial of survivin-derived peptide vaccine therapy for patients with advanced or recurrent oral cancerMIYAZAKI, Akihiro; KOBAYASHI, Junichi; NAGAI, Itaru et al.Cancer science. 2011, Vol 102, Num 2, pp 324-329, issn 1347-9032, 6 p.Article

Down-regulation of HLA class I antigens in prostate cancer tissues and up-regulation by histone deacetylase inhibitionKITAMURA, Hiroshi; TORIGOE, Toshihiko; ASANUMA, Hiroko et al.The Journal of urology. 2007, Vol 178, Num 2, pp 692-696, issn 0022-5347, 5 p.Article

Identification of an Immunogenic CTL Epitope of HIFPH3 for Immunotherapy of Renal Cell CarcinomaSATO, Eiji; TORIGOE, Toshihiko; ITO, Naoki et al.Clinical cancer research (Print). 2008, Vol 14, Num 21, pp 6916-6923, issn 1078-0432, 8 p.Article

Expression of livin in renal cell carcinoma and detection of anti-livin autoantibody in patientsKITAMURA, Hiroshi; HONMA, Ichiya; TORIGOE, Toshihiko et al.Urology (Ridgewood, NJ). 2007, Vol 70, Num 1, pp 38-42, issn 0090-4295, 5 p.Article

Prognostic significance of HLA class I expression in osteosarcoma defined by anti-pan HLA class I monoclonal antibody, EMR8-5TSUKAHARA, Tomohide; KAWAGUCHI, Satoshi; WADA, Takuro et al.Cancer science. 2006, Vol 97, Num 12, pp 1374-1380, issn 1347-9032, 7 p.Article

HSP DNAJB8 Controls Tumor-Initiating Ability in Renal Cancer Stem―like CellsNISHIZAWA, Satoshi; HIROHASHI, Yoshihiko; SOKOLOVSKAYA, Alice et al.Cancer research (Chicago, Ill.). 2012, Vol 72, Num 11, pp 2844-2854, issn 0008-5472, 11 p.Article

The feasibility of Cep55/c10orf3 derived peptide vaccine therapy for colorectal carcinomaINODA, Satoko; MORITA, Rena; TERUI, Takeshi et al.Experimental and molecular pathology. 2011, Vol 90, Num 1, pp 55-60, issn 0014-4800, 6 p.Article

Down-regulation of HLA class I antigen is an independent prognostic factor for clear cell renal cell carcinoma. CommentaryKITAMURA, Hiroshi; HONMA, Ichiya; TORIGOE, Toshihiko et al.The Journal of urology. 2007, Vol 177, Num 4, pp 1269-1272, issn 0022-5347, 4 p.Article

A potent immunogenic general cancer vaccine that targets survivin, an inhibitor of apoptosis proteinsIDENOUE, Satomi; HIROHASHI, Yoshihiko; KANASEKI, Takayuki et al.Clinical cancer research. 2005, Vol 11, Num 4, pp 1474-1482, issn 1078-0432, 9 p.Article

Cytotoxic T Lymphocytes Efficiently Recognize Human Colon Cancer Stem-Like CellsINODA, Satoko; HIROHASHI, Yoshihiko; TERUI, Takeshi et al.The American journal of pathology. 2011, Vol 178, Num 4, pp 1805-1813, issn 0002-9440, 9 p.Article

Novel spliced form of a lens protein as a novel lung cancer antigen, Lengsin splicing variant 4NAKATSUGAWA, Munehide; HIROHASHI, Yoshihiko; TAMURA, Yasuaki et al.Cancer science. 2009, Vol 100, Num 8, pp 1485-1493, issn 1347-9032, 9 p.Article

Effect of human leukocyte antigen class I expression of tumor cells on outcome of intravesical instillation of bacillus calmette-guerin immunotherapy for bladder cancerKITAMURA, Hiroshi; TORIGOE, Toshihiko; HONMA, Ichiya et al.Clinical cancer research. 2006, Vol 12, Num 15, pp 4641-4644, issn 1078-0432, 4 p.Article

Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cellsASANUMA, Hiroko; TORIGOE, Toshihiko; KAMIGUCHI, Kenjiro et al.Cancer research (Baltimore). 2005, Vol 65, Num 23, pp 11018-11025, issn 0008-5472, 8 p.Article

SOX2 is overexpressed in stem-like cells of human lung adenocarcinoma and augments the tumorigenicityNAKATSUGAWA, Munehide; TAKAHASHI, Akari; KONDO, Toru et al.Laboratory investigation. 2011, Vol 91, Num 12, pp 1796-1804, issn 0023-6837, 9 p.Article

A novel isoform of TUCAN is overexpressed in human cancer tissues and suppresses both caspase-8- and caspase-9-mediated apoptosisYAMAMOTO, Masaaki; TORIGOE, Toshihiko; OHMURA, Tousei et al.Cancer research (Baltimore). 2005, Vol 65, Num 19, pp 8706-8714, issn 0008-5472, 9 p.Article

Expression of matrix metalloproteinase 9 is a prognostic factor in patients with non-hodgkin lymphomaSAKATA, Koh-Ichi; SATOH, Masaaki; HIMI, Tetsuo et al.Cancer. 2004, Vol 100, Num 2, pp 356-365, issn 0008-543X, 10 p.Article

Identification of human autologous cytotoxic T-lymphocyte-defined osteosarcoma gene that encodes a transcriptional regulator, papillomavirus binding factorTSUKAHARA, Tomohide; NABETA, Yuki; HIRAGA, Hiroaki et al.Cancer research (Baltimore). 2004, Vol 64, Num 15, pp 5442-5448, issn 0008-5472, 7 p.Article

Cep55/c10orf3, a Tumor Antigen Derived From a Centrosome Residing Protein in Breast CarcinomaINODA, Satoko; HIROHASHI, Yoshihiko; ASANUMA, Hiroko et al.Journal of immunotherapy (1997). 2009, Vol 32, Num 5, pp 474-485, issn 1524-9557, 12 p.Article

Expression and antigenicity of survivin, an inhibitor of apoptosis family member, in bladder cancer : Implications for specific immunotherapyKITAMURA, Hiroshi; TORIGOE, Toshihiko; HONMA, Ichiya et al.Urology (Ridgewood, NJ). 2006, Vol 67, Num 5, pp 955-959, issn 0090-4295, 5 p.Article

Aberrant expression and potency as a cancer immunotherapy target of inhibitor of apoptosis protein family, Livin/ML-IAP in lung cancerHARIU, Hiroyuki; HIROHASHI, Yoshihiko; MANO, Yoshinori et al.Clinical cancer research. 2005, Vol 11, Num 3, pp 1000-1009, issn 1078-0432, 10 p.Article

Abnormal β-catenin expression in oral cancer with no gene mutation : correlation with expression of cyclin D1 and epidermal growth factor receptor, Ki-67 labeling index, and clinicopathological featuresODAJIMA, Tetsuyo; SASAKI, Yasushi; TANAKA, Nobuyuki et al.Human pathology. 2005, Vol 36, Num 3, pp 234-241, issn 0046-8177, 8 p.Article